安達維爾(300719.SZ)一季度預虧1100萬元-1400萬元
格隆匯4月15日丨安達維爾(300719.SZ)公佈2022年第一季度業績預吿,公司預計實現歸屬於上市公司股東的淨虧損為1100萬元-1400萬元。
報吿期內,營業收入較上年同期有所下降,主要原因為機載設備業務部分產品收入未能在報吿期內確認,公司積極應對,目前合同簽訂及驗收等工作推進正常,同時,客户部分重大項目採購已陸續啟動,公司防務核心產品通過競標等方式均參與其中,有望逐漸形成產值;報吿期內公司收到的增值税退税及政府補貼同比下降,公司正在辦理符合條件的銷售合同的相關退税手續,後續將陸續收到退税款項;另外,2021年度實施的第二類限制性股權激勵,也增加了本報吿期的股份支付費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.